The Toronto-Dominion Bank
TD
Canadian Imperial Bank of Commerce
CM
Royal Bank of Canada
RY
Bank of Nova Scotia
BNS
Bank of Montreal
BMO
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -276.34%-597.24K | 147.14%759.79K | -109.70%-326.85K | -731.23%-1.13M | -15.95%300.37K | 341.01%338.7K | -1,845.84%-1.61M | -448.20%-155.87K | 617.66%178.77K | -49.57%357.36K |
Net income from continuing operations | -394.45%-376.63K | -96.87%9.36K | -11.92%-270.21K | 73.85%-445.82K | 69.15%-427.01K | -241.17%-76.17K | 277.47%298.8K | -17.02%-241.44K | -30.72%-1.7M | -546.42%-1.38M |
Operating gains losses | --0 | 103.25%24.06K | -240.49%-37.28K | -2,843.44%-693.43K | 229.36%63.16K | 62.09%-42.65K | -79,522.26%-740.49K | -85.85%26.54K | 121.84%25.28K | -137.73%-48.83K |
Depreciation and amortization | 1,079.08%59.47K | -127.32%-1.88K | 18.33%30.56K | -8.37%121.09K | 192.58%83.34K | -85.64%5.04K | -80.16%6.88K | -23.79%25.83K | -2.66%132.16K | -41.65%28.49K |
Asset impairment expenditure | ---- | ---- | ---- | -104.02%-41.18K | ---- | ---- | ---- | ---- | -35.58%1.02M | ---- |
Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 94.25%-3.67K | ---- |
Other non cashItems | -239.97%-7.42K | -100.58%-146 | -76.83%5.05K | -27.77%60.97K | 169.00%8.52K | -90.59%5.3K | 29.23%25.35K | 4.92%21.79K | 2.41%84.4K | -90.45%-12.35K |
Change In working capital | -161.57%-274.85K | 160.57%728.61K | -621.72%-55.51K | -122.62%-141.77K | -8.07%604.19K | 408.15%446.38K | -1,757.60%-1.2M | -74.49%10.64K | 462.30%626.65K | 126.40%657.21K |
-Change in receivables | -151.50%-75.53K | 147.81%622.91K | -14.41%-341.51K | -136.58%-286.02K | 28.35%1.17M | 145.41%146.65K | -835.47%-1.3M | -1,844.51%-298.5K | 671.45%781.99K | 2,688.05%910.66K |
-Change in payables and accrued expense | 257.78%316.42K | -471.63%-371.63K | -7.49%285.99K | -208.42%-11.27K | -480.17%-508.86K | -50.34%88.44K | 195.61%100K | 1,156.37%309.14K | 102.95%10.4K | -148.57%-87.71K |
-Change in other working capital | ---515.74K | ---- | ---- | 193.83%155.52K | ---55.77K | ---- | ---- | ---- | -313.55%-165.74K | ---- |
Interest received (cash flow from operating activities) | 176.96%2.19K | -126.08%-206 | -29.91%539 | 55.98%3.21K | -14.54%858 | 11.11%790 | 138.67%790 | 7,590.00%769 | 604.11%2.06K | 243.84%1K |
Tax refund paid | ---- | --0 | --0 | 208.20%8.5K | -91.05%8.5K | --0 | --0 | --0 | 95.80%-7.86K | 9,502,300.00%95.02K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -276.34%-597.24K | 147.14%759.79K | -109.70%-326.85K | -731.23%-1.13M | -15.95%300.37K | 341.01%338.7K | -1,845.84%-1.61M | -448.20%-155.87K | 617.66%178.77K | -49.57%357.36K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | -100.27%-6.1K | -30.85%-1.09K | 6,050.68%2.2M | -2,636.00%-47.96K | 0 | 34,325.74%2.25M | 44.65%-833 | 102.08%35.79K | -125.73%-1.75K |
Net PPE purchase and sale | --0 | -100.27%-6.1K | -30.85%-1.09K | 6,050.68%2.2M | -2,636.00%-47.96K | --0 | 34,325.74%2.25M | 44.65%-833 | 11.03%35.79K | -124.81%-1.75K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | -100.27%-6.1K | -30.85%-1.09K | 6,050.68%2.2M | -2,636.00%-47.96K | --0 | 34,325.74%2.25M | 44.65%-833 | 102.08%35.79K | -125.73%-1.75K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 83.99%-17.4K | 64.29%-412.16K | -89.92%-284.72K | -1,263.36%-1.71M | -185.38%-292.64K | 30.73%-108.67K | -642.08%-1.15M | 3.56%-149.91K | -110.59%-125.1K | 282.89%342.77K |
Net issuance payments of debt | 77.93%-22.64K | 63.44%-412.52K | -119.18%-279.13K | -207.18%-1.64M | -121.10%-283.27K | 24.55%-102.57K | -731.96%-1.13M | 5.43%-127.35K | 50.37%-534.34K | 33.83%-128.12K |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | 185.92%5.24K | 101.35%352 | 75.23%-5.59K | 25.78%-64.17K | 62.22%-9.38K | 70.85%-6.09K | -31.04%-26.14K | -8.57%-22.56K | -4.53%-86.46K | -500.92%-24.82K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --495.7K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 83.99%-17.4K | 64.29%-412.16K | -89.92%-284.72K | -1,263.36%-1.71M | -185.38%-292.64K | 30.73%-108.67K | -642.08%-1.15M | 3.56%-149.91K | -110.59%-125.1K | 282.89%342.77K |
Net cash flow | ||||||||||
Beginning cash position | -3.88%2.58M | -26.55%2.19M | -21.43%2.74M | -8.44%3.49M | -10.16%2.89M | -23.45%2.68M | -20.33%2.98M | -8.44%3.49M | -17.11%3.81M | -8.45%3.21M |
Current changes in cash | -367.20%-614.64K | 166.19%341.53K | -99.81%-612.66K | -807.36%-632.78K | -105.76%-40.23K | 191.36%230.03K | -110.64%-515.96K | -173.29%-306.62K | 115.67%89.46K | 32.28%698.37K |
Effect of exchange rate changes | 967.08%207.43K | -78.37%47.19K | 129.34%59.59K | 72.20%-114.27K | 75.10%-105.41K | 34.18%-23.92K | 2,525.82%218.18K | -602.74%-203.12K | -90.95%-411.01K | -85.68%-423.38K |
End cash Position | -24.86%2.17M | -3.88%2.58M | -26.55%2.19M | -21.43%2.74M | -21.43%2.74M | -10.16%2.89M | -23.45%2.68M | -20.33%2.98M | -8.44%3.49M | -8.44%3.49M |
Free cash from | -276.34%-597.24K | 146.77%753.69K | -109.28%-327.94K | -782.09%-1.13M | -16.37%297.41K | 336.07%338.7K | -1,702.75%-1.61M | -462.24%-156.7K | 301.69%166K | -50.31%355.61K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.